As the autumn vaccination programme is now underway, regulators have approved another drug designed to fight the Omicron variant of covid.
Swissmedic says the new Pfizer jab can be rolled out across the country.
Like the Moderna vaccine currently in use – the new drug will target the BA.1 Omicron variant – although later mutations are now circulating.
But Pfizer does have another product which is awaiting approval which the makers claim will be effective against the BA.4 and BA.5 variants.
Border closures and checks start today
French strike hits train services
Geneva votes to ban religious symbols
The US is not seen as reliable
Swiss companies invest billions in the US
Heatwaves becoming more normal
